(JAZZ) Jazz Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Jazz Pharmaceuticals | (JAZZ) share price targets
Complete technical analysis of Jazz Pharmaceuticals (JAZZ) by charts plus indicators, forecast predictions and share price targets for Jazz Pharmaceuticals (JAZZ)
Jazz Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-03 View latest technical analysis
10 day averaged volume of Jazz Pharmaceuticals is 753390
| Date | Daily Closing Price | Open | High | Low | Volume |
| 03 Thu Oct 2024 | 108.56 | 109.83 | 109.83 | 108.09 | 0.499 times |
| 02 Wed Oct 2024 | 109.70 | 108.66 | 110.33 | 108.07 | 0.93 times |
| 01 Tue Oct 2024 | 109.04 | 111.41 | 111.97 | 107.51 | 0.917 times |
| 30 Mon Sep 2024 | 111.41 | 110.83 | 112.20 | 110.40 | 0.574 times |
| 27 Fri Sep 2024 | 110.93 | 110.91 | 112.83 | 110.06 | 0.664 times |
| 26 Thu Sep 2024 | 110.19 | 108.02 | 110.63 | 108.00 | 0.706 times |
| 25 Wed Sep 2024 | 107.86 | 109.45 | 109.45 | 107.00 | 0.836 times |
| 24 Tue Sep 2024 | 109.08 | 109.35 | 110.29 | 108.63 | 0.664 times |
| 23 Mon Sep 2024 | 108.99 | 111.17 | 111.79 | 108.00 | 0.769 times |
| 20 Fri Sep 2024 | 110.76 | 110.81 | 111.45 | 109.43 | 2.649 times |
My analysis of stock is bearish for shortterm, and stock might move down till 107.2 or till 105.1. Use a stoploss of 108.98 and if the stock hits stoploss, then it can shoot up till 110.76
Share price targets for Jazz Pharmaceuticals (JAZZ)
| Target Type | Value |
| Downside Target | 99.06 |
| Downside Target | 104.27 |
| Upside Target | 111.97 |
| Upside Target | 112.20 |
| Upside Target | 112.83 |
| Upside Target | 113.00 |
| Upside Target | 113.30 |
| Upside Target | 113.60 |
| Upside Target | 115.24 |
| Upside Target | 117.77 |
Intraday share price targets for Jazz Pharmaceuticals (JAZZ)
| Target Type | Value |
| Downside Intraday Target | 106.65 |
| Downside Intraday Target | 104.73 |
| Upside Intraday Target | 111.34 |
| Upside Intraday Target | 114.11 |
| Upside Intraday Target | 109.42 |
Weekly technical analysis of Jazz Pharmaceuticals (JAZZ)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 03 Thu Oct 2024 | 108.56 | 110.83 | 112.20 | 107.51 | 0.802 times |
| 27 Fri Sep 2024 | 110.93 | 111.17 | 112.83 | 107.00 | 0.592 times |
| 20 Fri Sep 2024 | 110.76 | 110.00 | 113.30 | 108.99 | 1.7 times |
| 13 Fri Sep 2024 | 108.79 | 107.44 | 108.86 | 104.42 | 0.341 times |
| 06 Fri Sep 2024 | 107.14 | 112.00 | 113.60 | 105.99 | 21.85 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Jazz Pharmaceuticals (JAZZ)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 03 Thu Oct 2024 | 108.56 | 111.41 | 111.97 | 107.51 | 0.095 times |
| 30 Mon Sep 2024 | 111.41 | 112.00 | 113.60 | 104.42 | 1.472 times |
| 30 Fri Aug 2024 | 115.98 | 113.15 | 117.77 | 107.27 | 1.031 times |
| 31 Wed Jul 2024 | 110.25 | 106.73 | 113.00 | 99.06 | 0.716 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Jazz Pharmaceuticals (JAZZ)
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Jazz Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Jazz Pharmaceuticals in short term and the sell signal is strong.
Jazz Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Jazz Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Jazz Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 109.84 and Jazz Pharmaceuticals (JAZZ) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Jazz Pharmaceuticals (JAZZ) stock. Volume based technical analysis of Jazz Pharmaceuticals (JAZZ) stock is negative.
Jazz Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Jazz Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Jazz Pharmaceuticals in short term and the sell signal is strong.
Jazz Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Jazz Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Jazz Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 109.84 and Jazz Pharmaceuticals (JAZZ) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Jazz Pharmaceuticals (JAZZ) stock. Volume based technical analysis of Jazz Pharmaceuticals (JAZZ) stock is negative.
Jazz Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.